Zentalis Pharmaceuticals

IPO

Clinical oncology innovator

Public · San Diego, United States · Founded 2014 · $147.1M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$147.1M
Last Round
$85.0M Series CDec 2019
Rounds
3
Type
Public

About

Zentalis Pharmaceuticals is a clinical-stage oncology company focused on developing internally discovered small molecule cancer therapies. The company's lead program is an investigational WEE1 inhibitor being evaluated for ovarian cancer and multiple other tumor types, with a Phase 3 clinical trial (ASPENOVA) initiated in 2026. Founded in 2014 and headquartered in San Diego, California, Zentalis is led by a seasoned team of oncology executives with experience advancing drugs from discovery through regulatory approval and commercial launch.

Summary

Zentalis Pharmaceuticals is a Healthcare company based in San Diego, United States, founded in 2014. It has raised $147.1M in total across 3 rounds, most recently a $85.0M Series C round in Dec 2019. Investors include Pfizer Ventures and Redmile Group.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOApr 2020
$165.0M

Sign up to see all 4 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zentalis Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/zentalis-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/zentalis-pharmaceuticals" alt="Zentalis Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>